{
  "docId": "019de514-c6ee-70fe-9ed1-115332e66453",
  "docSlug": "7d8148a830366811cd98c46e453c2fa7",
  "documentTitle": "Adagio Therapeutics | Investor Conference Presentation Deck | 10 slides",
  "authorId": "adagio-therapeutics",
  "authorName": "Invivyd",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 10,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "other",
  "function": "establish_context",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de514-c6ee-70fe-9ed1-115332e66453/3",
  "deckHref": "/decks/019de514-c6ee-70fe-9ed1-115332e66453",
  "deckJsonHref": "/decks/019de514-c6ee-70fe-9ed1-115332e66453.json",
  "deckAnchorHref": "/decks/019de514-c6ee-70fe-9ed1-115332e66453#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.28,
        "w": 0.199,
        "x": 0.07,
        "y": 0.483
      },
      "kind": "list",
      "text": "Antibodies designed to protect humanity from serious viral diseases\nInitial focus on COVID-19 with antibodies designed towards addressing variants of concern",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "44e3b5ac-4f4b-42bc-abf1-063c8d937965",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.28,
        "w": 0.199,
        "x": 0.73,
        "y": 0.483
      },
      "kind": "list",
      "text": "Growing number of antibodies aiming to overcome the challenges of viral evolution, starting in COVID-19\nPlans to expand into other respiratory viruses with ongoing preclinical activity in influenza",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "452acd14-6d41-4de7-8550-d26e48fc2207",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.199,
        "x": 0.51,
        "y": 0.483
      },
      "kind": "list",
      "text": "NVD200 for COVID-19; a combination monoclonal antibody product\nPhase 1 trial start planned for Q1 2023",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "93aee5e8-2b41-449b-8e3c-5df0042f4c10",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.199,
        "x": 0.29,
        "y": 0.483
      },
      "kind": "list",
      "text": "Rapid antibody isolation, engineering, and predictive modeling of viral evolution\nIdentification and engineering of antibodies across multiple dimensions such as potency, durability, half-life, potential to resist escape, and manufacturability",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e6dace45-c089-4b70-b248-134ce5ffd4b6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.429,
        "x": 0.045,
        "y": 0.13
      },
      "kind": "title",
      "text": "OVERVIEW OF INVIVYD",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "776b928a-98e8-42e9-b4fd-4efd7db96c47",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "c9a19578-c406-48d9-88af-f0579a0a212c",
      "evidence": "list/bullet: Rapid antibody isolation, engineering, and predictive modeling of viral evolution",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 3,
      "from": 3,
      "beatId": "ea9908c7-0a38-4d3d-aa44-b5f7a595a6fd",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem (Identify pain)",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "The overview of Invivyd and the context of COVID-19 variants",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}